Chenevix-Trench G - Search Results

1

RAD52 Y415X truncation polymorphism and epithelial ovarian cancer risk in Australian women.

Kelemen L, Spurdle AB, Purdie DM, Gertig D, Chenevix-Trench G. Kelemen L, et al. Cancer Lett. 2005 Feb 10;218(2):191-7. doi: 10.1016/j.canlet.2004.09.023. Cancer Lett. 2005. PMID: 15670896

2

Increased expression of the NME1 gene is associated with metastasis in epithelial ovarian cancer.

Leary JA, Kerr J, Chenevix-Trench G, Doris CP, Hurst T, Houghton CR, Friedlander ML. Leary JA, et al. Int J Cancer. 1995 Jun 22;64(3):189-95. doi: 10.1002/ijc.2910640308. Int J Cancer. 1995. PMID: 7622307

3

Rare mutations and no hypermethylation at the CDKN2A locus in epithelial ovarian tumours.

Shih YC, Kerr J, Liu J, Hurst T, Khoo SK, Ward B, Wainwright B, Chenevix-Trench G. Shih YC, et al. Int J Cancer. 1997 Mar 4;70(5):508-11. doi: 10.1002/(sici)1097-0215(19970304)70:5<508::aid-ijc3>3.0.co;2-1. Int J Cancer. 1997. PMID: 9052747

4

Analysis of loss of heterozygosity and KRAS2 mutations in ovarian neoplasms: clinicopathological correlations.

Chenevix-Trench G, Kerr J, Hurst T, Shih YC, Purdie D, Bergman L, Friedlander M, Sanderson B, Zournazi A, Coombs T, Leary JA, Crawford E, Shelling AN, Cooke I, Ganesan TS, Searle J, Choi C, Barrett JC, Khoo SK, Ward B. Chenevix-Trench G, et al. Genes Chromosomes Cancer. 1997 Feb;18(2):75-83. doi: 10.1002/(sici)1098-2264(199702)18:2<75::aid-gcc1>3.0.co;2-y. Genes Chromosomes Cancer. 1997. PMID: 9115967

5

Fertility and incidence of KRAS2 mutations in borderline ovarian adenocarcinomas.

Chenevix-Trench G, Coombs T, Kerr J, Purdie D, Green A, Cummings MC. Chenevix-Trench G, et al. J Natl Cancer Inst. 1997 Jun 18;89(12):890-1. doi: 10.1093/jnci/89.12.890. J Natl Cancer Inst. 1997. PMID: 9196259 No abstract available.

6

Relationship between number of ovulatory cycles and accumulation of mutant p53 in epithelial ovarian cancer.

Webb PM, Green A, Cummings MC, Purdie DM, Walsh MD, Chenevix-Trench G. Webb PM, et al. J Natl Cancer Inst. 1998 Nov 18;90(22):1729-34. doi: 10.1093/jnci/90.22.1729. J Natl Cancer Inst. 1998. PMID: 9827528

7

Androgen receptor exon 1 CAG repeat length and breast cancer in women before age forty years.

Spurdle AB, Dite GS, Chen X, Mayne CJ, Southey MC, Batten LE, Chy H, Trute L, McCredie MR, Giles GG, Armes J, Venter DJ, Hopper JL, Chenevix-Trench G. Spurdle AB, et al. J Natl Cancer Inst. 1999 Jun 2;91(11):961-6. doi: 10.1093/jnci/91.11.961. J Natl Cancer Inst. 1999. PMID: 10359549

8

beta-catenin mutation and expression analysis in ovarian cancer: exon 3 mutations and nuclear translocation in 16% of endometrioid tumours.

Wright K, Wilson P, Morland S, Campbell I, Walsh M, Hurst T, Ward B, Cummings M, Chenevix-Trench G. Wright K, et al. Int J Cancer. 1999 Aug 27;82(5):625-9. doi: 10.1002/(sici)1097-0215(19990827)82:5<625::aid-ijc1>3.0.co;2-2. Int J Cancer. 1999. PMID: 10417756

9

CYP17 promotor polymorphism and ovarian cancer risk.

Spurdle AB, Chen X, Abbazadegan M, Martin N, Khoo SK, Hurst T, Ward B, Webb PM, Chenevix-Trench G. Spurdle AB, et al. Int J Cancer. 2000 May 1;86(3):436-9. doi: 10.1002/(sici)1097-0215(20000501)86:3<436::aid-ijc21>3.0.co;2-a. Int J Cancer. 2000. PMID: 10760835

10

Androgen receptor exon 1 CAG repeat length and risk of ovarian cancer.

Spurdle AB, Webb PM, Chen X, Martin NG, Giles GG, Hopper JL, Chenevix-Trench G. Spurdle AB, et al. Int J Cancer. 2000 Sep 1;87(5):637-43. Int J Cancer. 2000. PMID: 10925355

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

579 results

Search Page

Filters